twins, or lack of follow-up were excluded.
Women with elevated levels of maternal serum alpha-fetoprotein (MS-AFP) commonly undergo prenatal sonography for detection of possible fetal malformations, notably neural tube defects. Other common reasons for elevated MS-AFP levels include incorrect gestational age, multiple gestations, and death of the fetus [1 ] . However, even when accounting for these conditions, no apparent explanation is found in the vast majority of women with abnormally elevated MS-AFP levels [1] .
Recent reports suggest that placental abnormalities [2] [3] [4] [5] [6] and oligohydramnios [7] [8] [9] may be associated with elevated MS-AFP levels. However, the frequency of such observations is uncertain because of the small number of published series. In order to determine the frequency of placental abnormalities and oligohydramnios in women with an apparently normal fetus and an elevated MS-AFP level, we compared sonographic findings in these patients with findings in a control population.
Materials and Methods
The initial study population consisted of 107 consecutive patients referred for sonographic evaluation during a 3-year period (1 985-1 987) with the clinical indication of an MS-AFP level greater than or equal to 2.5 multiples of the median level. If necessary, corrections for maternal weight or diabetes were made. All serum samples were obtained between 16 and 20 weeks gestational age. Twenty-two patients were excluded because of fetal anomalies (eight cases), incorrect dates (1 0 cases), or twins (four cases) that explained the elevated MS-AFP level. Nine other patients were eliminated from the study group because of a lack of follow-up (four cases) or referral to sonography after 24 weeks gestational age (five cases), Fig. 1 
Results
The results of the study are compiled in Table 1 
' :
i.-.. . An abnormally thickened placenta ( 3.5 cm) was found in nine patients (1 2%) with elevated MS-AFP levels (Fig. 4) compared with four control patients (5%) (p = .23).
; i T
In patients with elevated MS-AFP levels, clinical outcome included normal delivery in 53 cases (70%), fetal or neonatal death in 1 may be associated with elevated MS-AFP levels. We speculate that maternal lakes may form at sites of previous hemorrhage in this situation.
In addition to placental sonolucencies, sonographic evidence of periplacental hemorrhage was associated with elevated MS-AFP levels in the present study (Fig. 2) . Seven patients (9%) with elevated MS-AFP levels had evidence of periplacental hemorrhage [1 9] , and all hemorrhages were located near the margin of the placenta or beneath the chorionic membrane (Fig. 2) . In comparison, Fleischer et al. [6] reported periplacental hematomas in 16 [18] .
Thickened placentas (Fig. 4) and placenta previa were observed more often in patients with elevated MS-AFP levels than in the control group in the present study, although these associations did not reach statistical significance. Nevertheless, a thickened placenta or placenta previa in patients with an elevated MS-AFP level may be a helpful ancillary finding in conjunction with other sonographic abnormalities.
The association between midtrimester oligohydramnios and elevated MS-AFP level noted in the present study (Fig. 3) confirms earlier observations [7] [8] [9] .
In the absence of genitourinary anomalies, the cause of oligohydramnios in these pregnancies is uncertain, but it has been suggested that it reflects an underlying uteroplacental insufficiency [9] . Fetal hypoxemia may result in shunting of blood away from the fetal kidneys and secondarily in decreased urine production and decreased amniotic fluid volume [9] . 
